These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 8313396

  • 1. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA.
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [Abstract] [Full Text] [Related]

  • 2. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF.
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR, Antonin KH, Schmidt E.
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [Abstract] [Full Text] [Related]

  • 4. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM, de Leon J.
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 6. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL, Page RL, Ruscin JM.
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [Abstract] [Full Text] [Related]

  • 7. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993 Aug; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

  • 8. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH.
    J Clin Psychiatry; 2007 Aug; 68 Suppl 8():42-6. PubMed ID: 17640157
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
    Lotufo-Neto F, Trivedi M, Thase ME.
    Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
    [Abstract] [Full Text] [Related]

  • 10. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM.
    J Clin Psychiatry; 2012 Mar; 73 Suppl 1():25-30. PubMed ID: 22951239
    [Abstract] [Full Text] [Related]

  • 11. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E, Chodera A.
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [Abstract] [Full Text] [Related]

  • 12. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL, Ascher JA.
    Clin Neuropharmacol; 1993 Jul; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [Abstract] [Full Text] [Related]

  • 13. Monoamine oxidase B inhibition and the "cheese effect".
    Youdim MB, Finberg JP.
    J Neural Transm Suppl; 1987 Jul; 25():27-33. PubMed ID: 3480939
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ, Swope DM, Dashtipour K.
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase inhibitors: reversible and irreversible.
    Rudorfer MV.
    Psychopharmacol Bull; 1992 Sep; 28(1):45-57. PubMed ID: 1609042
    [Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase inhibitors. An update on drug interactions.
    Livingston MG, Livingston HM.
    Drug Saf; 1996 Apr; 14(4):219-27. PubMed ID: 8713690
    [Abstract] [Full Text] [Related]

  • 17. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    Holt A, Berry MD, Boulton AA.
    Neurotoxicology; 2004 Jan; 25(1-2):251-66. PubMed ID: 14697900
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 19. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL, Garrick NA, Aulakh CS, Cohen RM.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [Abstract] [Full Text] [Related]

  • 20. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
    Herraiz T, Chaparro C.
    Biochem Biophys Res Commun; 2005 Jan 14; 326(2):378-86. PubMed ID: 15582589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.